Sandbox:Sahar: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 33: | Line 33: | ||
==Treatment== | ==Treatment== | ||
Currently, there is no curative medication for this disease and supportive care is only available.<br>I need my text to be <font | Currently, there is no curative medication for this disease and supportive care is only available.<br>I need my text to be <font color="blue">blue</font>. | ||
==References== | ==References== | ||
{{Reflist|2}} | {{Reflist|2}} | ||
Revision as of 17:49, 31 January 2019
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]
Overview
Historical Perspective
This disease named after the name of Martin XXXX.
Pathophysiology
This disease is fif;nkf;n,;nd/;FN<gmnfnl;mfng/lm,h/,fn.[1]
Classification
Hyperparathyroidism is classified into three categories:
- Primary
- Secondary
- Psudosecondary
- Tertiary
Dignostic Methods
There are different methods to diagnose this disease.
Ultrasound
CT Scan
Radiopedia
Treatment
Currently, there is no curative medication for this disease and supportive care is only available.
I need my text to be blue.
References
- ↑ Özdel S, Özçakar ZB, Cakar N, Aydın F, Çelikel E, Elhan AH; et al. (2018). "Fatigue in pediatric patients with familial Mediterranean fever". Mod Rheumatol. 28 (6): 1016–1020. doi:10.1080/14397595.2018.1427459. PMID 29322855.